FinancialReconSpine

Medtech mergers stayed strong in Q3

November 12, 2014 by Brad Perriello

Merger & acquisition activity in the medtech sector stayed strong during the 3rd quarter, according to PricewaterhouseCoopers.

The merger & acquisition frenzy that consumed the medical device industry during the 2nd quarter stayed strong during the ensuing period, although the value of the Q3 deals slipped a bit, according to PricewaterhouseCoopers.

Medtech posted more deals during Q3, going from 11 to 13 deals on a sequential-quarter basis, according to PwC’s Pharmaceutical & Life Sciences Deals Insights Quarterly.

But the value of the deals declined from $5.6 billion to $3.6 billion during the 3rd quarter, compared with Q2, and slid 38.1% from Q3 2013, according to the report.

READ THE REST AT MASSDEVICE

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close